Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Acne not improved by usual treatments may indicate a genetic disorder.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Alginate-Chitosan-Fucoidan sponges speed up wound healing effectively.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

New tests detect finasteride and dutasteride in urine quickly and easily.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.

Corin helps control salt and sweat release in sweat glands.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

N-acetylcysteine improved symptoms of trichotillomania and bulimia.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.